Functional and Structural Characterization of Neutralizing Epitopes of Measles Virus Hemagglutinin Protein

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:

Bibliographic Details
Published in	Journal of Virology Vol. 87; no. 1; pp. 666 - 675
Main Authors	Tahara, Maino, Ito, Yuri, Brindley, Melinda A., Ma, Xuemin, He, Jilan, Xu, Songtao, Fukuhara, Hideo, Sakai, Kouji, Komase, Katsuhiro, Rota, Paul A., Plemper, Richard K., Maenaka, Katsumi, Takeda, Makoto
Format	Journal Article
Language	English
Published	United States American Society for Microbiology 01.01.2013
Subjects	Antibodies, Monoclonal - immunology Antibodies, Neutralizing - immunology Epitopes - genetics Epitopes - immunology Humans Measles virus - genetics Measles virus - immunology Mutant Proteins - genetics Mutant Proteins - immunology Neutralization Tests Viral Proteins - genetics Viral Proteins - immunology Virus-Cell Interactions
Online Access	Get full text

Cover

Loading…

Abstract	Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI
AbstractList	Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI Effective vaccination programs have dramatically reduced the number of measles-related deaths globally. Although all the available data suggest that measles eradication is biologically feasible, a structural and biochemical basis for the single serotype nature of measles virus (MV) remains to be provided. The hemagglutinin (H) protein, which binds to two discrete proteinaceous receptors, is the major neutralizing target. Monoclonal antibodies (MAbs) recognizing distinct epitopes on the H protein were characterized using recombinant MVs encoding the H gene from different MV genotypes. The effects of various mutations on neutralization by MAbs and virus fitness were also analyzed, identifying the location of five epitopes on the H protein structure. Our data in the present study demonstrated that the H protein of MV possesses at least two conserved effective neutralizing epitopes. One, which is a previously recognized epitope, is located near the receptor-binding site (RBS), and thus MAbs that recognize this epitope blocked the receptor binding of the H protein, whereas the other epitope is located at the position distant from the RBS. Thus, a MAb that recognizes this epitope did not inhibit the receptor binding of the H protein, rather interfered with the hemagglutinin-fusion (H-F) interaction. This epitope was suggested to play a key role for formation of a higher order of an H-F protein oligomeric structure. Our data also identified one nonconserved effective neutralizing epitope. The epitope has been masked by an N -linked sugar modification in some genotype MV strains. These data would contribute to our understanding of the antigenicity of MV and support the global elimination program of measles. Effective vaccination programs have dramatically reduced the number of measles-related deaths globally. Although all the available data suggest that measles eradication is biologically feasible, a structural and biochemical basis for the single serotype nature of measles virus (MV) remains to be provided. The hemagglutinin (H) protein, which binds to two discrete proteinaceous receptors, is the major neutralizing target. Monoclonal antibodies (MAbs) recognizing distinct epitopes on the H protein were characterized using recombinant MVs encoding the H gene from different MV genotypes. The effects of various mutations on neutralization by MAbs and virus fitness were also analyzed, identifying the location of five epitopes on the H protein structure. Our data in the present study demonstrated that the H protein of MV possesses at least two conserved effective neutralizing epitopes. One, which is a previously recognized epitope, is located near the receptor-binding site (RBS), and thus MAbs that recognize this epitope blocked the receptor binding of the H protein, whereas the other epitope is located at the position distant from the RBS. Thus, a MAb that recognizes this epitope did not inhibit the receptor binding of the H protein, rather interfered with the hemagglutinin-fusion (H-F) interaction. This epitope was suggested to play a key role for formation of a higher order of an H-F protein oligomeric structure. Our data also identified one nonconserved effective neutralizing epitope. The epitope has been masked by an N-linked sugar modification in some genotype MV strains. These data would contribute to our understanding of the antigenicity of MV and support the global elimination program of measles.Effective vaccination programs have dramatically reduced the number of measles-related deaths globally. Although all the available data suggest that measles eradication is biologically feasible, a structural and biochemical basis for the single serotype nature of measles virus (MV) remains to be provided. The hemagglutinin (H) protein, which binds to two discrete proteinaceous receptors, is the major neutralizing target. Monoclonal antibodies (MAbs) recognizing distinct epitopes on the H protein were characterized using recombinant MVs encoding the H gene from different MV genotypes. The effects of various mutations on neutralization by MAbs and virus fitness were also analyzed, identifying the location of five epitopes on the H protein structure. Our data in the present study demonstrated that the H protein of MV possesses at least two conserved effective neutralizing epitopes. One, which is a previously recognized epitope, is located near the receptor-binding site (RBS), and thus MAbs that recognize this epitope blocked the receptor binding of the H protein, whereas the other epitope is located at the position distant from the RBS. Thus, a MAb that recognizes this epitope did not inhibit the receptor binding of the H protein, rather interfered with the hemagglutinin-fusion (H-F) interaction. This epitope was suggested to play a key role for formation of a higher order of an H-F protein oligomeric structure. Our data also identified one nonconserved effective neutralizing epitope. The epitope has been masked by an N-linked sugar modification in some genotype MV strains. These data would contribute to our understanding of the antigenicity of MV and support the global elimination program of measles. Effective vaccination programs have dramatically reduced the number of measles-related deaths globally. Although all the available data suggest that measles eradication is biologically feasible, a structural and biochemical basis for the single serotype nature of measles virus (MV) remains to be provided. The hemagglutinin (H) protein, which binds to two discrete proteinaceous receptors, is the major neutralizing target. Monoclonal antibodies (MAbs) recognizing distinct epitopes on the H protein were characterized using recombinant MVs encoding the H gene from different MV genotypes. The effects of various mutations on neutralization by MAbs and virus fitness were also analyzed, identifying the location of five epitopes on the H protein structure. Our data in the present study demonstrated that the H protein of MV possesses at least two conserved effective neutralizing epitopes. One, which is a previously recognized epitope, is located near the receptor-binding site (RBS), and thus MAbs that recognize this epitope blocked the receptor binding of the H protein, whereas the other epitope is located at the position distant from the RBS. Thus, a MAb that recognizes this epitope did not inhibit the receptor binding of the H protein, rather interfered with the hemagglutinin-fusion (H-F) interaction. This epitope was suggested to play a key role for formation of a higher order of an H-F protein oligomeric structure. Our data also identified one nonconserved effective neutralizing epitope. The epitope has been masked by an N-linked sugar modification in some genotype MV strains. These data would contribute to our understanding of the antigenicity of MV and support the global elimination program of measles.
Author	Richard K. Plemper Makoto Takeda Melinda A. Brindley Songtao Xu Katsuhiro Komase Kouji Sakai Hideo Fukuhara Xuemin Ma Yuri Ito Jilan He Maino Tahara Paul A. Rota Katsumi Maenaka
Author_xml	– sequence: 1 givenname: Maino surname: Tahara fullname: Tahara, Maino organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 2 givenname: Yuri surname: Ito fullname: Ito, Yuri organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan – sequence: 3 givenname: Melinda A. surname: Brindley fullname: Brindley, Melinda A. organization: Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA – sequence: 4 givenname: Xuemin surname: Ma fullname: Ma, Xuemin organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 5 givenname: Jilan surname: He fullname: He, Jilan organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 6 givenname: Songtao surname: Xu fullname: Xu, Songtao organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 7 givenname: Hideo surname: Fukuhara fullname: Fukuhara, Hideo organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan – sequence: 8 givenname: Kouji surname: Sakai fullname: Sakai, Kouji organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 9 givenname: Katsuhiro surname: Komase fullname: Komase, Katsuhiro organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 10 givenname: Paul A. surname: Rota fullname: Rota, Paul A. organization: Measles, Mumps, Rubella and Herpesviruses Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 11 givenname: Richard K. surname: Plemper fullname: Plemper, Richard K. organization: Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA – sequence: 12 givenname: Katsumi surname: Maenaka fullname: Maenaka, Katsumi organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan – sequence: 13 givenname: Makoto surname: Takeda fullname: Takeda, Makoto organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/23115278$$D View this record in MEDLINE/PubMed
BookMark	eNp1kc9PFDEcxRuDkWXh5tnM0YOD_d3OxcRsQDCoJArx1nSH7852M9MubQcjf70dFoyaeGqb9-n7fvPeAdrzwQNCLwk-JoTqtx-vz48xxYzVhD5DM4IbXQtB-B6aYUxpLZj-vo8OUtpgTDiX_AXap4wQQZWeoc3p6Nvsgrd9Zf1N9TXHsc1jLM_F2kbbZoju3k5EFVbVZxhz0dy98111snU5bCFNwiewqS_XaxfHVJ3BYLuuH7PzzleXMWRw_hA9X9k-wdHjOUdXpyffFmf1xZcP54v3F3XLlci1VcsGiJaalvUVVUpSbBuQjHHMuCZMCqJ5g6nFAFK1iqiVZFSLpqHNkis2R-92vttxOcBNC35a2WyjG2z8aYJ15m_Fu7Xpwp1hgkmmZDF4_WgQw-0IKZvBpRb63noIYzKEsgaLpoRY0Fd_zvo95CngAtAd0MaQUoSVaV1-iLOMdr0h2EwtmtKieWhxcp-jN_98evL9D17t8LXr1j9cBGPTYDZ3zmhliJFSsl-uy6jg
CitedBy_id	crossref_primary_10_1016_j_virusres_2017_04_018 crossref_primary_10_1371_journal_pone_0073374 crossref_primary_10_1128_JVI_01945_13 crossref_primary_10_3390_v8040109 crossref_primary_10_1038_nrdp_2016_49 crossref_primary_10_1038_s41598_019_52345_9 crossref_primary_10_1128_jvi_01949_21 crossref_primary_10_1016_j_meegid_2019_103943 crossref_primary_10_1155_2014_205617 crossref_primary_10_1016_j_virol_2014_01_027 crossref_primary_10_3390_v9010011 crossref_primary_10_1016_j_vaccine_2015_12_006 crossref_primary_10_1093_infdis_jiv434 crossref_primary_10_1128_JVI_00209_17 crossref_primary_10_2222_jsv_67_3 crossref_primary_10_1111_1348_0421_12238 crossref_primary_10_1016_j_biologicals_2019_03_009 crossref_primary_10_2217_fmb_14_137 crossref_primary_10_1111_febs_14991 crossref_primary_10_3390_v8080216 crossref_primary_10_1093_infdis_jiw480 crossref_primary_10_1007_s00430_016_0451_4 crossref_primary_10_1038_nri_2017_148 crossref_primary_10_1186_s12985_018_1027_2 crossref_primary_10_15406_jhvrv_2017_05_00172 crossref_primary_10_1016_j_coviro_2020_02_007 crossref_primary_10_1371_journal_pone_0192245 crossref_primary_10_1016_j_virusres_2014_11_015 crossref_primary_10_3389_fmicb_2022_1088243 crossref_primary_10_1016_j_chom_2023_09_012 crossref_primary_10_1007_s12026_020_09159_z crossref_primary_10_1093_femspd_ftw089 crossref_primary_10_1128_JVI_03029_12 crossref_primary_10_1371_journal_pone_0195256 crossref_primary_10_1073_pnas_1403609111 crossref_primary_10_3390_vaccines10081227 crossref_primary_10_3390_vaccines12070810 crossref_primary_10_1038_srep11648 crossref_primary_10_1128_JVI_03298_12
Cites_doi	10.1128/JVI.76.13.6743-6749.2002 10.1046/j.1432-1033.2003.03517.x 10.1128/JVI.05067-11 10.1006/viro.1999.9644 10.1128/JVI.01264-07 10.1093/infdis/170.4.795 10.1099/0022-1317-77-10-2479 10.1093/infdis/jir118 10.1007/s11262-011-0638-0 10.1128/jcm.19.1.21-25.1984 10.1128/JVI.02691-07 10.1128/jvi.69.1.513-516.1995 10.1016/j.virusres.2011.09.023 10.1074/jbc.M110.102590 10.1128/JVI.01222-10 10.1074/jbc.M112.342493 10.1089/088282402760312331 10.1016/0042-6822(92)90742-8 10.1016/j.meegid.2005.08.003 10.1128/JVI.01195-09 10.1111/j.1365-3083.1989.tb01205.x 10.1093/infdis/jir133 10.1128/JVI.00867-08 10.1038/nsmb.1969 10.1099/0022-1317-78-6-1295 10.1128/JVI.02449-06 10.1016/j.virol.2008.10.018 10.1006/viro.1993.1042 10.1073/pnas.0707830104 10.1093/infdis/jir111 10.1038/nature10639 10.1002/j.1460-2075.1995.tb00266.x 10.1099/vir.0.013524-0 10.1128/jvi.64.2.700-705.1990 10.1128/jvi.68.3.1486-1493.1994 10.1099/vir.0.014944-0 10.1128/JVI.74.14.6643-6647.2000 10.1128/JVI.76.10.5051-5061.2002 10.1111/j.1348-0421.1993.tb03205.x 10.1038/35022579 10.1007/s00705-003-0159-9 10.1128/JVI.79.24.15218-15225.2005 10.1371/journal.ppat.1002240 10.1128/JVI.75.9.4399-4401.2001 10.1016/S0140-6736(05)71877-8 10.1128/JVI.79.17.11547-11551.2005 10.1099/vir.0.80467-0 10.1016/S0140-6736(03)12661-X 10.1111/j.1348-0421.2003.tb03424.x 10.1099/0022-1317-66-7-1397
ContentType	Journal Article
Copyright	Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
Copyright_xml	– notice: Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM
DOI	10.1128/JVI.02033-12
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE CrossRef
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	1098-5514
EndPage	675
ExternalDocumentID	PMC3536376 23115278 10_1128_JVI_02033_12 jvi_87_1_666
Genre	Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NIAID NIH HHS grantid: AI083402 – fundername: NIAID NIH HHS grantid: R01 AI083402 – fundername: NIAID NIH HHS grantid: R56 AI083402
GroupedDBID	--- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM CGR CUY CVF ECM EIF NPM 7X8 5PM
ID	FETCH-LOGICAL-c475t-a7b9e186820027277620a9e633403481365184902a0ee67c717f632859929b473
ISSN	0022-538X 1098-5514
IngestDate	Thu Aug 21 17:51:25 EDT 2025 Fri Jul 11 16:14:20 EDT 2025 Thu Apr 03 07:09:31 EDT 2025 Thu Apr 24 23:05:55 EDT 2025 Tue Jul 01 01:02:19 EDT 2025 Wed May 18 15:26:09 EDT 2016
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c475t-a7b9e186820027277620a9e633403481365184902a0ee67c717f632859929b473
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://jvi.asm.org/content/jvi/87/1/666.full.pdf
PMID	23115278
PQID	1239059231
PQPubID	23479
PageCount	10
ParticipantIDs	crossref_primary_10_1128_JVI_02033_12 crossref_citationtrail_10_1128_JVI_02033_12 highwire_asm_jvi_87_1_666 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3536376 proquest_miscellaneous_1239059231 pubmed_primary_23115278
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	20130101 2013-01-00 2013-Jan
PublicationDateYYYYMMDD	2013-01-01
PublicationDate_xml	– month: 01 year: 2013 text: 20130101 day: 01
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: 1752 N St., N.W., Washington, DC
PublicationTitle	Journal of Virology
PublicationTitleAlternate	J Virol
PublicationYear	2013
Publisher	American Society for Microbiology
Publisher_xml	– name: American Society for Microbiology
References	e_1_3_3_50_2 e_1_3_3_16_2 Leonard VH (e_1_3_3_41_2) 2008; 118 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_33_2 e_1_3_3_54_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_52_2 e_1_3_3_40_2 e_1_3_3_5_2 e_1_3_3_7_2 Takeda M (e_1_3_3_9_2) 2011; 2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_23_2 e_1_3_3_48_2 e_1_3_3_25_2 e_1_3_3_46_2 e_1_3_3_44_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 e_1_3_3_51_2 e_1_3_3_17_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_36_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_32_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_53_2 WHO (e_1_3_3_13_2) 2012; 87 e_1_3_3_6_2 e_1_3_3_8_2 e_1_3_3_28_2 e_1_3_3_49_2 e_1_3_3_24_2 e_1_3_3_47_2 e_1_3_3_26_2 e_1_3_3_45_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_4_2 e_1_3_3_22_2 2474850 - Scand J Immunol. 1989 Aug;30(2):225-31 17715217 - J Virol. 2007 Nov;81(21):12091-6 21917959 - J Virol. 2011 Nov;85(22):11871-82 14579178 - Arch Virol. 2003 Nov;148(11):2195-206 21901103 - PLoS Pathog. 2011 Aug;7(8):e1002240 10087234 - Virology. 1999 Mar 30;256(1):142-51 12620751 - Lancet. 2003 Mar 1;361(9359):763-73 2410551 - J Gen Virol. 1985 Jul;66 ( Pt 7):1397-409 22431728 - J Biol Chem. 2012 May 11;287(20):16324-34 15659756 - J Gen Virol. 2005 Feb;86(Pt 2):365-74 9191921 - J Gen Virol. 1997 Jun;78 ( Pt 6):1295-302 18799577 - J Virol. 2008 Dec;82(23):11979-84 1566568 - Virology. 1992 May;188(1):135-42 12479395 - Viral Immunol. 2002;15(3):451-71 2153236 - J Virol. 1990 Feb;64(2):700-5 18568079 - J Clin Invest. 2008 Jul;118(7):2448-58 8887481 - J Gen Virol. 1996 Oct;77 ( Pt 10):2479-89 19013625 - Virology. 2009 Jan 5;383(1):1-5 20435897 - J Biol Chem. 2010 Jul 2;285(27):20882-90 19656895 - J Virol. 2009 Oct;83(20):10480-93 16103210 - J Virol. 2005 Sep;79(17):11547-51 7983748 - J Virol. 1995 Jan;69(1):513-6 8846771 - EMBO J. 1995 Dec 1;14(23):5773-84 7508996 - J Virol. 1994 Mar;68(3):1486-93 11967321 - J Virol. 2002 May;76(10):5051-61 17182683 - J Virol. 2007 Mar;81(6):2564-72 7930720 - J Infect Dis. 1994 Oct;170(4):795-801 20861270 - J Virol. 2010 Dec;84(23):12174-84 14524622 - Microbiol Immunol. 2003;47(8):613-7 16306593 - J Virol. 2005 Dec;79(24):15218-25 11287589 - J Virol. 2001 May;75(9):4399-401 18003910 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40 12654007 - Eur J Biochem. 2003 Apr;270(7):1515-27 10864679 - J Virol. 2000 Jul;74(14):6643-7 22462199 - Wkly Epidemiol Rec. 2012 Mar 2;87(9):73-81 21963661 - Virus Res. 2011 Dec;162(1-2):72-9 10972291 - Nature. 2000 Aug 24;406(6798):893-7 12050387 - J Virol. 2002 Jul;76(13):6743-9 21666216 - J Infect Dis. 2011 Jul;204 Suppl 1:S71-7 19710253 - J Gen Virol. 2009 Dec;90(Pt 12):2982-9 7685966 - Virology. 1993 Jan;192(1):351-4 21666150 - J Infect Dis. 2011 Jul;204 Suppl 1:S1-3 6361060 - J Clin Microbiol. 1984 Jan;19(1):21-5 18287234 - J Virol. 2008 May;82(9):4630-7 22347873 - Front Microbiol. 2012 Jan 13;2:279 19625457 - J Gen Virol. 2009 Nov;90(Pt 11):2739-45 8321151 - Microbiol Immunol. 1993;37(3):233-7 22048310 - Nature. 2011 Dec 22;480(7378):530-3 16172023 - Infect Genet Evol. 2006 Jul;6(4):269-76 21701857 - Virus Genes. 2011 Dec;43(3):319-26 21217702 - Nat Struct Mol Biol. 2011 Feb;18(2):135-41 15794969 - Lancet. 2005 Mar 26-Apr 1;365(9465):1147-52 21666208 - J Infect Dis. 2011 Jul;204 Suppl 1:S514-23
References_xml	– ident: e_1_3_3_31_2 doi: 10.1128/JVI.76.13.6743-6749.2002 – ident: e_1_3_3_53_2 doi: 10.1046/j.1432-1033.2003.03517.x – ident: e_1_3_3_34_2 doi: 10.1128/JVI.05067-11 – volume: 87 start-page: 73 year: 2012 ident: e_1_3_3_13_2 article-title: Measles virus nomenclature update: 2012 publication-title: Wkly. Epidemiol. Rec. – ident: e_1_3_3_46_2 doi: 10.1006/viro.1999.9644 – ident: e_1_3_3_25_2 doi: 10.1128/JVI.01264-07 – ident: e_1_3_3_16_2 doi: 10.1093/infdis/170.4.795 – ident: e_1_3_3_52_2 doi: 10.1099/0022-1317-77-10-2479 – ident: e_1_3_3_47_2 doi: 10.1093/infdis/jir118 – ident: e_1_3_3_15_2 doi: 10.1007/s11262-011-0638-0 – ident: e_1_3_3_28_2 doi: 10.1128/jcm.19.1.21-25.1984 – ident: e_1_3_3_33_2 doi: 10.1128/JVI.02691-07 – ident: e_1_3_3_27_2 doi: 10.1128/jvi.69.1.513-516.1995 – ident: e_1_3_3_5_2 doi: 10.1016/j.virusres.2011.09.023 – ident: e_1_3_3_21_2 doi: 10.1074/jbc.M110.102590 – ident: e_1_3_3_35_2 doi: 10.1128/JVI.01222-10 – ident: e_1_3_3_50_2 doi: 10.1074/jbc.M112.342493 – ident: e_1_3_3_11_2 doi: 10.1089/088282402760312331 – ident: e_1_3_3_44_2 doi: 10.1016/0042-6822(92)90742-8 – ident: e_1_3_3_17_2 doi: 10.1016/j.meegid.2005.08.003 – ident: e_1_3_3_37_2 doi: 10.1128/JVI.01195-09 – ident: e_1_3_3_51_2 doi: 10.1111/j.1365-3083.1989.tb01205.x – ident: e_1_3_3_4_2 doi: 10.1093/infdis/jir133 – ident: e_1_3_3_40_2 doi: 10.1128/JVI.00867-08 – ident: e_1_3_3_19_2 doi: 10.1038/nsmb.1969 – ident: e_1_3_3_48_2 doi: 10.1099/0022-1317-78-6-1295 – ident: e_1_3_3_32_2 doi: 10.1128/JVI.02449-06 – ident: e_1_3_3_38_2 doi: 10.1016/j.virol.2008.10.018 – ident: e_1_3_3_43_2 doi: 10.1006/viro.1993.1042 – ident: e_1_3_3_20_2 doi: 10.1073/pnas.0707830104 – ident: e_1_3_3_3_2 doi: 10.1093/infdis/jir111 – ident: e_1_3_3_8_2 doi: 10.1038/nature10639 – ident: e_1_3_3_30_2 doi: 10.1002/j.1460-2075.1995.tb00266.x – volume: 118 start-page: 2448 year: 2008 ident: e_1_3_3_41_2 article-title: Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed publication-title: J. Clin. Invest. – ident: e_1_3_3_14_2 doi: 10.1099/vir.0.013524-0 – ident: e_1_3_3_22_2 doi: 10.1128/jvi.64.2.700-705.1990 – ident: e_1_3_3_54_2 doi: 10.1128/jvi.68.3.1486-1493.1994 – ident: e_1_3_3_12_2 doi: 10.1099/vir.0.014944-0 – ident: e_1_3_3_29_2 doi: 10.1128/JVI.74.14.6643-6647.2000 – ident: e_1_3_3_36_2 doi: 10.1128/JVI.76.10.5051-5061.2002 – ident: e_1_3_3_45_2 doi: 10.1111/j.1348-0421.1993.tb03205.x – ident: e_1_3_3_6_2 doi: 10.1038/35022579 – ident: e_1_3_3_42_2 doi: 10.1007/s00705-003-0159-9 – ident: e_1_3_3_39_2 doi: 10.1128/JVI.79.24.15218-15225.2005 – ident: e_1_3_3_7_2 doi: 10.1371/journal.ppat.1002240 – ident: e_1_3_3_24_2 doi: 10.1128/JVI.75.9.4399-4401.2001 – ident: e_1_3_3_2_2 doi: 10.1016/S0140-6736(05)71877-8 – ident: e_1_3_3_10_2 doi: 10.1128/JVI.79.17.11547-11551.2005 – ident: e_1_3_3_18_2 doi: 10.1099/vir.0.80467-0 – ident: e_1_3_3_49_2 doi: 10.1016/S0140-6736(03)12661-X – ident: e_1_3_3_23_2 doi: 10.1111/j.1348-0421.2003.tb03424.x – volume: 2 start-page: 279 year: 2011 ident: e_1_3_3_9_2 article-title: Wild-type measles virus is intrinsically dual-tropic publication-title: Front. Microbiol. – ident: e_1_3_3_26_2 doi: 10.1099/0022-1317-66-7-1397 – reference: 10972291 - Nature. 2000 Aug 24;406(6798):893-7 – reference: 7930720 - J Infect Dis. 1994 Oct;170(4):795-801 – reference: 21666208 - J Infect Dis. 2011 Jul;204 Suppl 1:S514-23 – reference: 8887481 - J Gen Virol. 1996 Oct;77 ( Pt 10):2479-89 – reference: 11287589 - J Virol. 2001 May;75(9):4399-401 – reference: 16172023 - Infect Genet Evol. 2006 Jul;6(4):269-76 – reference: 16103210 - J Virol. 2005 Sep;79(17):11547-51 – reference: 6361060 - J Clin Microbiol. 1984 Jan;19(1):21-5 – reference: 2153236 - J Virol. 1990 Feb;64(2):700-5 – reference: 21666216 - J Infect Dis. 2011 Jul;204 Suppl 1:S71-7 – reference: 19710253 - J Gen Virol. 2009 Dec;90(Pt 12):2982-9 – reference: 21917959 - J Virol. 2011 Nov;85(22):11871-82 – reference: 20861270 - J Virol. 2010 Dec;84(23):12174-84 – reference: 9191921 - J Gen Virol. 1997 Jun;78 ( Pt 6):1295-302 – reference: 2410551 - J Gen Virol. 1985 Jul;66 ( Pt 7):1397-409 – reference: 7508996 - J Virol. 1994 Mar;68(3):1486-93 – reference: 19013625 - Virology. 2009 Jan 5;383(1):1-5 – reference: 21666150 - J Infect Dis. 2011 Jul;204 Suppl 1:S1-3 – reference: 18003910 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40 – reference: 17182683 - J Virol. 2007 Mar;81(6):2564-72 – reference: 12620751 - Lancet. 2003 Mar 1;361(9359):763-73 – reference: 18799577 - J Virol. 2008 Dec;82(23):11979-84 – reference: 16306593 - J Virol. 2005 Dec;79(24):15218-25 – reference: 19656895 - J Virol. 2009 Oct;83(20):10480-93 – reference: 1566568 - Virology. 1992 May;188(1):135-42 – reference: 18568079 - J Clin Invest. 2008 Jul;118(7):2448-58 – reference: 22431728 - J Biol Chem. 2012 May 11;287(20):16324-34 – reference: 8321151 - Microbiol Immunol. 1993;37(3):233-7 – reference: 21217702 - Nat Struct Mol Biol. 2011 Feb;18(2):135-41 – reference: 7685966 - Virology. 1993 Jan;192(1):351-4 – reference: 2474850 - Scand J Immunol. 1989 Aug;30(2):225-31 – reference: 22048310 - Nature. 2011 Dec 22;480(7378):530-3 – reference: 12479395 - Viral Immunol. 2002;15(3):451-71 – reference: 19625457 - J Gen Virol. 2009 Nov;90(Pt 11):2739-45 – reference: 21963661 - Virus Res. 2011 Dec;162(1-2):72-9 – reference: 18287234 - J Virol. 2008 May;82(9):4630-7 – reference: 21701857 - Virus Genes. 2011 Dec;43(3):319-26 – reference: 10087234 - Virology. 1999 Mar 30;256(1):142-51 – reference: 15659756 - J Gen Virol. 2005 Feb;86(Pt 2):365-74 – reference: 21901103 - PLoS Pathog. 2011 Aug;7(8):e1002240 – reference: 7983748 - J Virol. 1995 Jan;69(1):513-6 – reference: 15794969 - Lancet. 2005 Mar 26-Apr 1;365(9465):1147-52 – reference: 20435897 - J Biol Chem. 2010 Jul 2;285(27):20882-90 – reference: 17715217 - J Virol. 2007 Nov;81(21):12091-6 – reference: 22347873 - Front Microbiol. 2012 Jan 13;2:279 – reference: 12050387 - J Virol. 2002 Jul;76(13):6743-9 – reference: 11967321 - J Virol. 2002 May;76(10):5051-61 – reference: 8846771 - EMBO J. 1995 Dec 1;14(23):5773-84 – reference: 10864679 - J Virol. 2000 Jul;74(14):6643-7 – reference: 22462199 - Wkly Epidemiol Rec. 2012 Mar 2;87(9):73-81 – reference: 14524622 - Microbiol Immunol. 2003;47(8):613-7 – reference: 14579178 - Arch Virol. 2003 Nov;148(11):2195-206 – reference: 12654007 - Eur J Biochem. 2003 Apr;270(7):1515-27
SSID	ssj0014464
Score	2.2931068
Snippet	Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... Effective vaccination programs have dramatically reduced the number of measles-related deaths globally. Although all the available data suggest that measles...
SourceID	pubmedcentral proquest pubmed crossref highwire
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	666
SubjectTerms	Antibodies, Monoclonal - immunology Antibodies, Neutralizing - immunology Epitopes - genetics Epitopes - immunology Humans Measles virus - genetics Measles virus - immunology Mutant Proteins - genetics Mutant Proteins - immunology Neutralization Tests Viral Proteins - genetics Viral Proteins - immunology Virus-Cell Interactions
Title	Functional and Structural Characterization of Neutralizing Epitopes of Measles Virus Hemagglutinin Protein
URI	http://jvi.asm.org/content/87/1/666.abstract https://www.ncbi.nlm.nih.gov/pubmed/23115278 https://www.proquest.com/docview/1239059231 https://pubmed.ncbi.nlm.nih.gov/PMC3536376
Volume	87
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db5swFLWyTpP2Mu17rNvkSdtTRBYwYHisulZNp1R7SKu8WYaalqohURMmNb9qP3H3GnBM2k3bXhACO4acg--9_jiXkE9Spkns5THEJjmHQ8DdJOeZG8R-kmL0k3i4d3h8Eh2dBsfTcNrr_bRWLVWrdJCt791X8j-owjXAFXfJ_gOy5kfhApwDvnAEhOH4VxgfglFqxvL0CkytBat1NPaNDvPa-IQnqtLDGmscHThYwKe8qBVnx0our-H0rLiplmCIZvLiAh8bdVe_o45Do85914eFGp1h-bEsynl_IrF1059UN0V_tJqbMrgD_lz29wY4MoEaD6b6tEKpk_5Y2mMRmBeiMxZhJpnsFafjYqMoZffEGAQznVYY7FDd-aK2KXpwdu_cmGObhXVXG9XZWu6aAB-3NRyfjQY4ycrcepW2xYbFTNPBR50hv84f1NXh3rKPZtXi1Y9CxFx4App-QB76EJhgzoyvo29m3gqC66DVp8e3a7da-PEX-4lQgrppvusPtRrV98U728t2LT9o8pQ8acCnezUbn5GeKp-TR3VK09sX5GrDSQqcpBtO0m1O0nlObU7SlpN4o-Ek1ZykHU7ShpMvyenhwWT_yG3yebhZwMOVK3maKEzPgAuDwG8GOzyUiYoYC4a4H5xFoRcHydCXQ6UinnGP5xFDhUXw4dOAs1dkp5yX6g2hHgtlyr00AMcriMIMamQqG8og4-l5xnKH9Nt_VWSN2D3mXLkWOuj1YwFwCA2H8HyHfDalF7XIy2_KOS1AQi5nwiaEQz62iAnooXHaTZZqXi2hHksgiAHAHfK6RtC00rLAIbyDrSmA6u_dO2VxqVXgWcgi8A7e_uGZdsnjzVf6juwA4uo9-NCr9IOm7S8is8q4
linkProvider	Flying Publisher
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+and+Structural+Characterization+of+Neutralizing+Epitopes+of+Measles+Virus+Hemagglutinin+Protein&rft.jtitle=Journal+of+Virology&rft.au=Maino+Tahara&rft.au=Yuri+Ito&rft.au=Melinda+A.+Brindley&rft.au=Xuemin+Ma&rft.date=2013-01-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=87&rft.issue=1&rft.spage=666&rft_id=info:doi/10.1128%2FJVI.02033-12&rft_id=info%3Apmid%2F23115278&rft.externalDBID=n%2Fa&rft.externalDocID=jvi_87_1_666
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon